Medpace Webinars

1. How Advanced Therapies Are Changing The Landscape Of Rare Disease 5/16/2019

   After years of innovative research, advanced therapies are dramatically changing the way patients are treated for a wide variety of diseases – particularly for patients with rare diseases and orphan indications. In this webinar join experts from Medpace’s medical, regulatory and operational team with hands-on experience in rare disease and ATMP development as they explore scientific advancements the regulatory landscape and lessons-learned and best practices for operationalizing rare disease clinical trials including identifying, enrolling and retaining patients, as well as special considerations for ATMPs.

2. Infectious Diseases In The Immunocompromised Host – A Dynamic Landscape With Challenges For Clinical Development 11/8/2018

   In this webinar, medical experts from Medpace’s Infectious Diseases and Hematology/Oncology teams discuss infectious diseases in the immunocompromised host—with a focus on hematologic malignancies and hematopoietic cell transplantation patients—and the unique challenges for clinical development.

3. Oncology Trial Recruitment: Challenging Indications And Challenging Studies 11/8/2018

   In this presentation, Medpace medical and operational experts discuss the trial design challenges for specific oncology populations and how to overcome them.

4. Special Considerations For Managing Immuno-oncology Studies 11/8/2018

   Lyon Gleich MD, and Jennifer L. Cutter PhD, engage in an interactive discussion on the topic of immuno-oncology and the unique challenges and considerations for managing clinical research.

5. What Happens After Your Device Is Approved? Collecting Data In The Real World 11/8/2018

   In this presentation, Medpace Medical Device experts discuss key considerations for generating real-world evidence and how to apply critical insights in order to drive late-stage clinical research.

6. Pharmacoeconomic Assessment Through Market Approval And Beyond: Theory And Operations 11/8/2018

   Pharmacoeconomic assessment of a drug, medical device, or other healthcare product can take on many forms and occur at multiple points in the development cycle. Cost-effectiveness analysis, a major component of pharmacoeconomic assessment, has traditionally occurred in the later phases of product development—either as a piggy-back to a phase III or pivotal clinical trial, or peri-authorization. Join Medpace experts as they explore the application of pharmacoeconomic assessment throughout all phases of clinical trials as well as in observational studies, including registries and other post-marketing data collection.

7. Planning And Executing A Clinical Study For An Orphan Indication 11/8/2018

   Planning and executing a clinical study for an orphan indication presents a unique set of challenges and considerations. In this webinar, Michelle Petersen, Medpace Clinical Trial Manager discusses successful strategies and best practices for addressing some of these including: unique methods to site selection and feasibility, successful recruitment/retention approaches, overview of common study execution needs, and optimal training and monitoring strategies.

8. Precision Medicine: Opportunities And Challenges For Clinical Trials 11/7/2018

   The momentum and muscle behind "finding the right drug for the right patient at the right dose" has further escalated with President Barack Obama’s announcement of a $215 million dollar Precision Medicine Initiative. In this webinar, Dr. Frank Smith will explore advances in precision medicine and how it is affecting clinical research. As a pediatric hematologist/oncologist, he will use his extensive clinical and research background as a backdrop for the discussion.

9. Rare Disease Disorders And CNS Drug Development – Paving The Way For Precision Medicine 11/7/2018

   In CNS drug development, more and more diseases once viewed as common are now known to be collections of rare variants. Our deepening understanding of the human genome and pathophysiology has led to fragmented classifications of common neurological or psychiatric disorders based on identified genetic markers. 

10. Getting Treatment Options To Rare Disease Patients Faster: Putting Patients First In Clinical Trials 11/6/2018

    In this webinar, Medpace discusses how patient-focused clinical trial design and collaborative approaches to site enrollment can accelerate clinical research. This presentation features a doctor from Cincinnati Children's Hospital Medical Center and a parent of a child with Duchenne muscular dystrophy.